81 related articles for article (PubMed ID: 7655146)
1. [Physicochemical compatibility of 5-fluorouracil (new french preparation) and folinic acid].
Milano G; Renée N
Bull Cancer; 1995 Mar; 82(3):189-95. PubMed ID: 7655146
[TBL] [Abstract][Full Text] [Related]
2. [Stability of 5-fluorouracil-folinic acid mixture: influence of concentrations, container and form of folinic acid].
Lokiec F; Amirault P; Bonnans H; Gauzan MF; Sauvage N; Santoni J
Bull Cancer; 1999 Nov; 86(11):946-54. PubMed ID: 10586111
[TBL] [Abstract][Full Text] [Related]
3. Long-term stability of 5-fluorouracil and folinic acid admixtures.
Milano G; Etienne MC; Cassuto-Viguier E; Renée N; Bousselet M; Guillot T; Lecompte D
Eur J Cancer; 1992; 29A(1):129-32. PubMed ID: 1445730
[TBL] [Abstract][Full Text] [Related]
4. Combination of reduced folates with methotrexate or 5-fluorouracil. Comparison between 5-formyltetrahydrofolate (folinic acid) and 5-methyltetrahydrofolate in vitro activities.
Etienne MC; Fischel JL; Formento P; Schneider M; Guillot T; Bardon M; Milano G
Biochem Pharmacol; 1993 Nov; 46(10):1767-74. PubMed ID: 8250962
[TBL] [Abstract][Full Text] [Related]
5. Long-term stability of 5-fluorouracil stored in PVC bags and in ambulatory pump reservoirs.
Martel P; Petit I; Pinguet F; Poujol S; Astre C; Fabbro M
J Pharm Biomed Anal; 1996 Feb; 14(4):395-9. PubMed ID: 8729637
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy for colorectal cancer.
Goyle S; Maraveyas A
Dig Surg; 2005; 22(6):401-14. PubMed ID: 16479107
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacokinetics of 5-fluorouracil. Influence of the biomodulating agents interferon, dipyridamole and folinic acid alone and in combination.
Czejka MJ; Jäger W; Schüller J; Fogl U; Weiss C; Schernthaner G
Arzneimittelforschung; 1993 Mar; 43(3):387-90. PubMed ID: 7683884
[TBL] [Abstract][Full Text] [Related]
8. A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial.
Ducreux M; Van Cutsem E; Van Laethem JL; Gress TM; Jeziorski K; Rougier P; Wagener T; Anak O; Baron B; Nordlinger B;
Eur J Cancer; 2005 Feb; 41(3):398-403. PubMed ID: 15691639
[TBL] [Abstract][Full Text] [Related]
9. Incompatibility of fluorouracil with leucovorin calcium or levoleucovorin calcium.
Trissel LA; Martinez JF; Xu QA
Am J Health Syst Pharm; 1995 Apr; 52(7):710-5. PubMed ID: 7627739
[TBL] [Abstract][Full Text] [Related]
10. Search for the optimal schedule for the oxaliplatin/5-fluorouracil association modulated or not by folinic acid: preclinical data.
Fischel JL; Etienne MC; Formento P; Milano G
Clin Cancer Res; 1998 Oct; 4(10):2529-35. PubMed ID: 9796987
[TBL] [Abstract][Full Text] [Related]
11. Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial.
Polyzos A; Tsavaris N; Giannopoulos A; Bacoyiannis C; Papadimas V; Kalahanis N; Karatzas G; Kosmas C; Sakelaropoulos N; Archimandritis A; Papachristodoulou A; Kosmidis P
Cancer Chemother Pharmacol; 1996; 38(3):292-7. PubMed ID: 8646806
[TBL] [Abstract][Full Text] [Related]
12. Weekly regimen of 5-FU vs 5-FU + intermediate dose folinic acid in the treatment of advanced colorectal cancer.
Martoni A; Cricca A; Guaraldi M; Covizzi M; Farris A; Pannuti F
Anticancer Res; 1992; 12(3):607-12. PubMed ID: 1622115
[TBL] [Abstract][Full Text] [Related]
13. Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 study.
Carlomagno C; Lauria R; De Laurentiis M; Arpino G; Massarelli E; Ferrara C; Milano A; Vernaglia Lombardi A; Costanzo R; Catalano G; Bianco AR; De Placido S
Oncology; 2002; 63(3):219-25. PubMed ID: 12381900
[TBL] [Abstract][Full Text] [Related]
14. Stability studies on admixtures of 5-fluorouracil with carboplatin and 5-fluorouracil with heparin for administration in continuous infusion regimens.
Sewell GJ; Allsopp M; Collinson MP; Tyrrell C; Prentice AJ; Copplestone JA
J Clin Pharm Ther; 1994 Apr; 19(2):127-33. PubMed ID: 8071393
[TBL] [Abstract][Full Text] [Related]
15. [Colorectal cancer: a controllable disease].
Bleiberg H; Gerard B
Rev Med Brux; 1997 Sep; 18(4):209-12. PubMed ID: 9411644
[TBL] [Abstract][Full Text] [Related]
16. Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer.
Poon MA; O'Connell MJ; Wieand HS; Krook JE; Gerstner JB; Tschetter LK; Levitt R; Kardinal CG; Mailliard JA
J Clin Oncol; 1991 Nov; 9(11):1967-72. PubMed ID: 1941055
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of a weekly 24-hour infusion with 5-fluorouracil and simultaneous sodium-folinic acid in the first-line treatment of metastatic colorectal cancer.
Hartung G; Hofheinz RD; Wein A; Riedel C; Rost A; Fritze D; Kreuser ED; Drees M; Kühnel J; Hehlmann R; Queisser W
Onkologie; 2001 Oct; 24(5):457-62. PubMed ID: 11694772
[TBL] [Abstract][Full Text] [Related]
18. [Sequential therapy with methotrexate and 5-fluorouracil in patients with advanced colorectal cancer pretreated with 5-fluorouracil plus folinic acid].
Paoletti G; Di Lauro L; Gionfra T; Venturo I; Belli F; Squilloni E; Mariotti S; Fioretti G; Gemini M; Tersigni R; Lopez M
Clin Ter; 1998; 149(2):105-8. PubMed ID: 9780473
[TBL] [Abstract][Full Text] [Related]
19. Hepatic arterial infusion (HAI). Comparison of 5-fluorouracil, folinic acid, interferon alpha-2b and degradable starch microspheres versus 5-fluorouracil and folinic acid in patients with non-resectable colorectal liver metastases.
Pohlen U; Rieger H; Mansmann U; Berger G; Buhr HJ
Anticancer Res; 2006; 26(5B):3957-64. PubMed ID: 17094427
[TBL] [Abstract][Full Text] [Related]
20. [Combination of 5-Fluorouracil and folinic acid--is it still the standard therapy for advanced colorectal carcinoma?].
Carnaghi C; Zucali P; Garassino I
Tumori; 2000; 86(5 Suppl 2):S19-25. PubMed ID: 11195298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
